Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Appointments
This week's roundup includes high level appointments by Merck KGaA, Chromocell Corporation, Kymab and GW Pharmaceuticals, in addition to board appointments by Fortuna Fix and Motif Bio.
The US rare diseases company Alexion appoints a new COO and is now looking for a new CFO, head of R&D, and head of human resources, as leadership changes leaves its CEO searching for a new executive team.
Biotech mourns the loss of one of its giants.
May has brought a flurry of new pharma executive moves in Japan and China.
This week's roundup includes CEO appointments by various companies including Mustang Bio, GammaDelta and Modus Therapeutics and other high-level appointments by Bayer, Renova, Metrion and Poxel.
As China moves to implement a raft of planned policy and regulatory changes, including opening up more to new drugs from multinationals, companies including Takeda appear to be ringing in personnel changes and increasingly hiring local executives to senior positions.
This week’s roundup includes high-level appointments by Almirall, Hookipa Biotech and RXi Pharmaceuticals, in addition to CEO appointments by Karolinska Development and ReForm Biologics and various board announcements by companies including Faron and Redx.
This week’s roundup includes the appointment of Sanofi Genzyme’s executive vice president and various high-level appointments by companies including Recipharm, e-Therapeutics, Diplomat Pharmacy and Axovant.
This week’s roundup includes various high-level appointments by companies including Vencerx Therapeutics, which has elected a new CEO, Shield Therapeutics, Crescendo Biologics, Pluristem Therapeutics, Sarepta Therapeutics and Verona Pharma.
China’s big three, Baidu, Alibaba and Tencent, deepen involvement in healthcare, hiring talent and eyeing digital health platforms.
Appointments: Impax, Mylan, Eisai, Cipher, Hutchison and Arena Pharmaceuticals, Bridge Medicines and ProMIS
This week's round up of recent appointments includes new CEOs at Impax Laboratories, Cipher Pharmaceuticals and Bridge Medicines, and other senior appointments at Mylan, Eisai and Arena Pharmaceuticals.
This week’s roundup includes CEO appointments by Smart Matrix and IRX Therapeutics, with various senior level appointments by companies including Therachon, Mission Therapeutics and bluebird bio.
You must sign in to use this functionality.
Please Sign In
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with active subscriptions will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.